Summan-Chemotherapy with the cytotoxic drug procarbazine (PCB) causes permanent infertility in most male patients. Since many patients treated with this cytotoxic drug are of reproductive age it is important to develop a method to protect spermatogenesis and fertility. It has been hypothesised that 'spermatogenic arrest' by pharmacological intervention may render the testes less susceptible to the effects of chemotherapy. The present study investigated whether recovery of fertility in a male rat model could be achieved by suppression of spermatogenesis with high doses of clomiphene citrate (CC) prior to PCB administration. It was demonstrated that young male rats treated with a combination of CC and PCB partially recovered spermatogenesis and achieved almost normal fertility. In contrast, animals treated with PCB alone exhibited abnormal spermatogenesis and remained infertile. (Weissenberg et al.. 1992) . although a few round spermatids were still apparent.
The increasing success of chemotherapy in prolongation of life of patients with various malignant and non-malignant diseases has called attention to late effects of cytotoxic treatment. including permanent sterility. For example, more than 80% of male patients treated with MOPP combination for Hodgkin's disease become either azoospermic or severely oligospermic (Whitehead et al., 1982) . Similar disorders have been noted to affect long-term survivors of acute leukaemia, testicular cancer. non-Hodgkin's lymphoma and collagen vascular diseases treated with cytotoxic drugs (Pennisi et al.. 1975 : Schilsky et al., 1980 : Drasga et al., 1983 . The main drugs that cause infertility are alkylating agents (Fairley et al.. 1972) . including nitrosoureas and procarbazine (PCB), however vinblastine and cisplatinum have also been implicated (Roeser et al.. 1978: Morris and . Since many patients are of reproductive age. it would be of importance to develop a method enabling some protection of spermatogenesis and fertility.
It has been suggested that 'spermatogenic arrest' caused by drug-induced blockage of the pituitary gonadal axis protects the testis from the effects of chemotherapy (Glode et al.. 1981) . It is well known that cytotoxic drugs affect mainly actively dividing cells, which in the testis are spermatogonia. However. 'spermatogenic arrest' does not completely stop mitosis in spermatogonia either following hypophysectomy (Clermont and Harvey. 1967) or as a result of drug-induced blockage of gonadotropin secretion. Thus, the mechanism by which the 'spermatogenic arrest' reduces testicular damage is still unclear.
Several authors have tried to protect the testis from chemotherapy by using different drugs. Gonadotropinreleasing hormone agonists have been shown to protect spermatogenesis in PCB-treated animals (Nseyo et al., 1985; Ward et al., 1990) , but not in humans (Johnson et al., 1985; Waxman, 1987: Kreuser and Hetzel, 1988) . In addition to work on features of testicular histology as criteria for gonadal protection, there are reports concerning the effect of PCB on other testicular parameters, such as testosterone and androgen-binding protein levels , and on reproductive function following chemotherapy or scrotal irradiation (Velez de la Calle and Jegou, 1990; Jegou et al.. 1991 (Heller et al., 1969 After 4 weeks of treatment with CC, three animals from group 1 were sacrificed and their testes were removed, weighed and processed for histological studies. At the end of the entire 8 week treatment period, four animals from each group were sacrificed and their testes were evaluated as above. The remaining animals were allowed to recover. Eight weeks following the recovery period mating experiments were carried out. Each male was caged with two proven fertile females during four consecutive oestrous cycles. The females were then removed and replaced with two other females, which were left with the males for the same penrod of time.
Pregnancy, birth and the number of pups per litter were recorded. At the end of the recovery period (i.e. about 13 weeks) the animals were sacrificed and the testes were removed, weighed and processed for histological studies. Paraffin sections were -stained with haematoxylin and eosin and photographed on an Olympus microscope. (Figure  2 ). In the rats treated with PCB only there was a difference between the effect of PCB at the termination of treatment as compared with that observed following recovery period. At the end of treatment, the majority of the tubules contained degenerated serpmatozoa formed before PCB administration, with shrunken germinal cells attached to the seminiferous tubule basal membrane. Further degeneration of seminiferous tubules was noted in this group following the recovery penod (Figure 3) (Figure 4) . The percentage of preserved seminiferous tubules varied among experimental animals with a mean of 51.7% ± 21.7% and a median of 52%. The difference in regeneration between the rats treated with PCB only and the CC + PCB-treated rats was statisically significant (P<O.001). Table H demonstrates the fertility of the various groups during the recovery period. This was expressed as the percentage of male rats which were able to impregnate females and the number of offspring per litter. CC-treated rats regained normal fertility, whereas PCB-treated rats remained sterile. Rats pretreated with CC and then given PCB gradually regained their fertility. The offspring were of normal birth weight and development at 6 weeks follow-up. Clomiphene did not interfere with the cytotoxic effect of PCB. The granulocyte counts in CC + PCB-treated animals decreased from 11 ± 3 x109 1-' before the administration of PCB to 3 ± 1.2 x 109 1-' 10 days after the end of treatment. This decrease was statistically significnt (P<0.001). The decrease in granulocyte count in rats treated with PCB only was similar-from 11.5 ±2 x 109 11 before the administration of Fugwe 4 Rat testis after combined treatment with CC and PCB, and followig the recovery perod. Loss of germnal epithelium is observed in some of the seminiferous tubules, while complete spermatogenesis is seen in the preserved tubules.
PCB to 3.5 ± 1 x 109 1-10 days after the treatment. These results show that co-administration of CC does not interfere with the cytotoxic effect of PCB.
Recent advances in chemotherapy and radiation therapy have significantly increased the life expectancy of patients with various malignant and non-malignant disorders. However, the occurrence of long-term side-effects, notably sterility, has become an important factor, especially in young patients. Various cytotoxic drugs cause gonadal damage and sterility. The MOPP regimen, commonly employed for treatment of Hodgkin's disease, causes irreversible sterility in men of reproductive age (Schilsky et al., 1980) . This effect is the result mainly of the PCB included in the drug combination. Treatment which would prevent or decrease the damage to germinal epithelium could significantly improve the quality of life of many patients.
This study presents the first evidence that the induction of spermatogenic arrest with the ministration of CC may preserve a high percentage of wminiferous tubules, eventually sustaining both spermatogenesis and reproductive function in PCB-treated rats.
In the present study we demonstrated that administration of CC may maintain spermatogenesis and reproductive potential in a PCB-treated rat model without signifcnt sideeffects. Moreover, although only a part of the seminiferous tubules exhibited active spermatogenesis after recovery from PCB treatment, the reproductive ability is nonetheless preserved. The evaluation of the clinical value of CC use in humans must consider and define the shortest period of pretreatment with CC before initiation of chemotherapy, as cytotoxic treatment cannot be withheld in order to achieve maximal spermatogenic arrest. These studies are currently being undertaken by our group. Since high doses of CC have been shown to cause azoospermia without significant sideeffects in men (Heller et al., 1969) , further research should establish the relevance of this model to man, as differences between the response to CC of rat and man regarding its effect on gonadotropin secretion might be expected. Clomiphene citrate, an oestrogen agonist-antagonist, is clnically employed for induction of ovulation and has been extensively studied for its effect on reproductive function in humans and in rats. In relatively high doses, CC has been shown to reversibly suppress gonadotropin secretion, decrease testosterone levels and cause spermatogenic arrest (Heller et al., 1969; Weissenberg et al., 1992 (Glode et al., 1981; Lewis et al., 1985; Ward et al., 1990) notwithstanding contrary views expressed on lack of grminal epithelium protection (da Cunha et al., 1987; Karashima et al., 1988; Papadopoulos, 1991) . Several of these studies pointed to suppression of (10/10) (10/10) (0/10) (0/10) (6/10)* (8/10)* (10/10) (10/10) Size oflitter 8 11 -8 10 10 11 (range) (7-10) (10-12) (1-11) (6-12) (8-12) (9-12) *P<0.01 vs PCB.
spermatogenesis and prevention of testicular damage in rats undergoing chemotherapy. Moreover, LH-RH analogue failed to protect fertility in men treated with the MOPP regimen for Hodgkin's disease (Johnson et al., 1985; Waxman, 1987) . Testosterone was found to protect approximately 22% of seminiferous tubules from damage by PCB in rats (Delic et al., 1986) . Oestrogen alone, however, failed to shield the germinal epithelium (Morris and Ward, 1989) , but addition of oestradiol to testosterone was found to enhance protection (Parchuri et al., 1993; Meistrich et al., 1994) . Clomiphene might have a direct oestrogenic effect on the testes and therefore acts as androgen antagonist. Direct effects on testicular RNA and protein synthesis have already been demonstrated (Hollinger 1970 (Hollinger , 1971 Hollinger and Hwang, 1972) . Flickinger (1977) 
